Edwards Lifesciences (EW)

Deferred Revenue

$20.30M

Quarterly · Period ending: · USD

EW logo

EW Deferred Revenue

Latest reported$20.30M
EW Quarterly Deferred Revenue ($0.00 → $20.30M)
High-resolution chart · PNG

EW deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
20,300,000
22,800,000
27,200,000
33,200,000
36,800,000
46,200,000
53,700,000
66,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.